Preclinical Testing Services

Welcome to our preclinical testing outsourcing services directory. Preclinical testing plays a critical role in the drug development process, enabling pharmaceutical companies to assess the safety, efficacy, and potential risks associated with new drug candidates before they advance to human trials. Within this directory exists a range of outsourcing partners offering specialized services to address various preclinical testing needs. From in vitro studies to animal model testing, from toxicology assessments to pharmacokinetic analyses, these experts possess the expertise and cutting-edge facilities necessary to support your specific application requirements. Whether you are focused on oncology, cardiovascular diseases, infectious diseases, or other therapeutic areas, this directory provides a comprehensive resource for discovering reliable and accredited service providers that can assist in accelerating your preclinical testing endeavors. By partnering with these industry-leading experts, you can navigate the complexities of preclinical testing with confidence, making informed decisions and optimizing your drug development strategy. Explore our Preclinical Testing Services directory and unlock the potential for success in your research and development initiatives.

  • Lifecore Adds Seventh Late-Stage Commercial Manufacturing Program

    Thursday, September 03, 2026
    Lifecore Biomedical has signed an agreement with an undisclosed global pharmaceutical company to transfer manufacturing of a currently marketed injectable drug product, adding what the company expects could become one of its largest commercial contracts. read more
  • Fortrea Agrees to $45M Purchase of Worldwide Early-Phase Unit

    Thursday, September 03, 2026
    Fortrea Holdings has agreed to acquire the Early Phase Services division of Worldwide Clinical Trials in an all-cash transaction valued at about $45 million, adding a Texas clinical pharmacology unit, bioanalytical laboratory and biospecimen storage operation to its early-development network. read more
  • Northway Biotech Opens $72 Million Cell-Therapy CDMO in Vilnius

    Thursday, September 03, 2026
    Northway Biotech has opened a $72 million cell-therapy and personalized-medicine contract development and manufacturing facility in Vilnius, Lithuania, expanding its capacity to develop and produce advanced therapies. read more
  • ARPA-H Awards Up to $125M for Distributed RNA Medicine Manufacturing

    Thursday, September 03, 2026
    The Advanced Research Projects Agency for Health has selected five teams for a program intended to develop automated, distributed manufacturing systems for individualized RNA-based genetic medicines, with up to $125 million available for research and development. read more
  • CPHI Milan Pharma Awards 2026 Finalists Announced

    Tuesday, September 01, 2026
    Informa Markets has announced the finalists for the CPHI Pharma Awards 2026, recognizing outstanding achievements across companies and individuals pushing the boundaries of science and technology to advance global healthcare. read more
  • Disabled_Documentary: A Solid Dosage Future

    In the pharmaceutical manufacturing space, while biopharmaceuticals often dominate discussions, it's crucial to acknowledge the enduring significance of solid dosage products (e.g., tablets, capsules, pills). These traditional forms remain the ...
  • A Solid Dosage Future

    In the pharmaceutical manufacturing space, while biopharmaceuticals often dominate discussions, it's crucial to acknowledge the enduring significance of solid dosage products (e.g., tablets, capsules, pills). These traditional forms remain the ...
We're sorry, no matching articles were found. Please select different filter options and try your search again.
We're sorry, no matching articles were found. Please select different filter options and try your search again.